IP Library Granted Patent US 9,888,674
Granted Patent B2
US 9,888,674 · App. 14/436,963 · Granted Feb 13, 2018

Double knockout (GT/CMAH-KO) pigs, organs and tissues

Inventor: A. Joseph Tector (Carmel, IN)
Assignee: Indiana University Research and Technology Corporation
A01K67/0276A61K35/407C12N9/0071C12N9/1048C12N9/22C12N9/2465C12N15/8509C12N15/8778C12N15/907A01K2217/00A01K2217/075A01K2217/15A01K2227/108A01K2267/025C07K2319/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,888,674
App. No.
14/436,963
Granted
Feb 13, 2018
Kind
B2
Abstract

The invention provides double knockout transgenic pigs (GT/CMAH-KO pigs) lacking expression of any functional aGAL and CMAH. Double knockout GT/CMAH-KO transgenic organs, tissues and cells are also provided. Methods of making and using the GT/CMAH-KO pigs and tissue are also provided.

Claims (3)

1. A knockout pig comprising disrupted α(1,3)-galactosyltransferase and CMAH genes, wherein the disruption of said α(1,3)-galactosyltransferase gene is selected from the group of disruptions to the sequence described in SEQ ID NO:18 comprising a 3 base pair deletion adjacent to a G to A substitution, and the group of disruptions to the sequence described in SEQ ID NO:24 comprising a single base pair deletion, a single base pair insertion, a six base pair deletion, a two base pair insertion, a ten base pair deletion, a seven base pair deletion, and an eight base pair substitution for a five base pair sequence; wherein the disruption of said CMAH gene is selected from the group of disruptions to the sequence described in SEQ ID NO:16 comprising a four base pair insertion, and the group of disruptions to the sequence described in SEQ ID NO:25 comprising a two base pair deletion, a single base pair insertion, an eight base pair deletion, a five base pair deletion, a three base pair deletion, a two base pair substitution for a single base pair, and a twenty base pair deletion; and wherein expression of functional α(1,3)-galactosyltransferase and CMAH in said knockout pig is decreased as compared to a wild-type pig and when tissue from said knockout pig is transplanted into a human, a hyperacute rejection related symptom is improved as compared to when tissue from a wild-type pig is transplanted into a human.

2. Porcine organs, tissues and cells obtained from the knockout pig of claim 1 .

3. A cell culture reagent obtained from the knockout pig of claim 1 , wherein the amount of Neu5Gc or alphaGal epitopes in said cell culture reagent is lower than the amount of Neu5Gc or alphaGal epitopes in a cell culture reagent obtained from a wild-type pig, and wherein said cell culture reagent is selected from the group consisting of cell culture media, cell culture serum, and an isolated cell capable of proliferation.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE INVENTORS NAME PREVIOUSLY RECORDED ON REEL 035446 FRAME 0403. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 18, 2015
From: TECTOR, A. JOSEPH
To: INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
Reel/Frame 036204/0295 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2015
From: TECTOR, JOSEPH A
To: INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
Reel/Frame 035446/0403 →
Continuity (3)
Continuation 13804365 · Mar 14, 2013
Provisional Application 61717845 · Oct 24, 2012
Related Publication 20150264900A1 · Sep 24, 2015